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CX3CR1
+andCD103+dendriticcells (DCs) in intestinal
lamina propria play a key role in mucosal immunity.
However, the origin and the developmental
pathways that regulate their differentiation in the
lamina propria remain unclear. We showed that
monocytes gave rise exclusively to CD103CX3CR1
+
lamina propria DCs under the control of macro-
phage-colony-stimulating factor receptor (M-CSFR)
and Fms-like thyrosine kinase 3 (Flt3) ligands. In
contrast, common DC progenitors (CDP) and pre-
DCs, which give rise to lymphoid organ DCs but
not to monocytes, differentiated exclusively into
CD103+CX3CR1
 lamina propria DCs under the
control of Flt3 and granulocyte-macrophage-colony-
stimulating factor receptor (GM-CSFR) ligands.
CD103+CX3CR1
 DCs but not CD103CX3CR1
+ DCs
in the lamina propria constitutively expressed CCR7
and were the first DCs to transport pathogenic
Salmonella from the intestinal tract to the mesenteric
lymph nodes. Altogether, these results underline the
diverse origin of the lamina propria DC network and
identify mucosal DCs that arise from pre-DCs as key
sentinels of the gut immune system.
INTRODUCTION
Under physiological conditions, the intestinal immune system is
tolerant to food antigens as well as to commensal bacteria,
whereas potent effector immune responses are induced to path-
ogenic microbes. How the discrimination between commensal
and pathogenic bacteria occurs is unclear, but several studies
suggest that mucosal dendritic cells (DCs) play a central role in
this process. DCs are present throughout the intestine in which
they reside in the lamina propria facing the lumen (Coombes and
Powrie, 2008; Johansson and Kelsall, 2005) and in the muscular
layers and the serosa facing the peritoneum (Flores-Langarica
et al., 2005). DCs also accumulate in intestinal lymphoid tissues
that include the Peyer’s patches (PPs) and isolated lymphoidIfollicles and in the mesenteric lymph nodes (MLNs) (Johansson
and Kelsall, 2005).
Although the phenotype of DCs in the PPs has been docu-
mented, the diversity of the lamina propria DCs is only starting
to be unraveled. A subset of lamina propria DCs expressing
the integrin aEb7 (also called CD103) (Cepek et al., 1994) have
a superior ability to induce the expression of gut homing mole-
cules on T lymphocytes and to drive the peripheral generation
of Foxp3+ T regulatory cells (Jaensson et al., 2008; Johansson-
Lindbom et al., 2005; Sung et al., 2006). CD103+ DCs with similar
functions were also described in the MLNs and were recently
shown to represent the main MLN DC population to present
oral antigens to T lymphocytes, suggesting that they originate
from the lamina propria (Coombes et al., 2007; Jaensson et al.,
2008; Johansson-Lindbom et al., 2005). Consistent with this
hypothesis, a study in the rat identified migratory CD103+ DCs
in the intestinal lymph in the steady state (Huang et al., 2000).
DCs that constitutively migrate to the MLNs deliver antigens
from both commensal bacteria (Macpherson and Uhr, 2004)
and apoptotic epithelial cells (Huang et al., 2000). Impairment
of constitutive DC trafficking to the MLNs in mice lacking
CCR7 results in defective induction of tolerance to oral antigens
(Worbs et al., 2006), establishing the importance of constitutive
antigen transport to the MLNs in mucosal integrity.
Another subset of lamina propria DCs characterized by the
expression of the fractalkin receptor CX3CR1 (Jung et al., 2000)
plays a key role in the sampling of luminal antigens. The exact
mechanisms by which lamina propria DCs sample gut antigens
that are transported to the MLNs continue to be an active area
of investigation. Several studies established that lamina propria
DCs in mice and humans sample antigens directly from the intes-
tinal lumen by projecting dendrites through the epithelial cell
layer and into the lumen (Chieppa et al., 2006; Niess et al.,
2005; Rescigno et al., 2001b). The ability of lamina propria DCs
to penetrate the epithelium is thought to provide a mechanism
by which apoptotic epithelial cells (Rescigno et al., 2001b) and
commensal organisms (Niess et al., 2005) could be captured
and transported to the MLNs. The formation of DC transepithelial
projections in the mouse lumen has been shown to be dependent
on CX3CR1 (Niess et al., 2005). Consistently, nonpathogenic
Escherichia coli was absent from the MLNs of mice that lack
CX3CR1 (Niess et al., 2005). However, the exact relationshipmmunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc. 513
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+ DCs specialized in the sampling of intes-
tinal antigens and the tissue migratory CD103+ DCs is unclear.
Recent studies characterized DC lineage commitment in the
bone marrow (BM). Lymphoid tissue DCs, plasmacytoid DCs,
and monocytes share a common progenitor called the macro-
phage and DC precursor (MDP) identified in the BM as linea-
geCD117hi CX3CR1
+CD115+ cells (Fogg et al., 2006), whereas
a distinct progenitor called the common DC precursor (CDP)
(LinCD117loCD115+ CD135+) arises from the MDP (Liu et al.,
2009) and is restricted to producing lymphoid organ DCs and
plasmacytoid DCs (Naik et al., 2007; Onai et al., 2007b). The
CDP also produce pre-cDCs, a cDC-restricted progenitor that
has lost plasmacytoid DC differentiation potential (Liu et al.,
2009). Pre-cDCs circulate through the blood to localize in
lymphoid organs in which they give rise to spleen and lymph no-
des DCs (Liu et al., 2009). Circulating monocytes are an excellent
source for DC generation in vitro but their contribution to DC
homeostasis in vivo is still unclear. Monocytes do not give rise
to lymphoid organ DCs in vivo in the steady state, but this can
occur during inflammation (Naik et al., 2006). In contrast, mono-
cytes have been shown to contribute to DC homeostasis in the
intestine in the noninflamed setting (Varol et al., 2007). Consistent
with this hypothesis, a study in the rat has shown that monocytes
give rise to tissue migratory DCs suggesting that monocytes
could contribute to the CD103+ lamina propria DCs (Yrlid et al.,
2006). These studies lead to the hypothesis that monocytes repre-
sent a major contributor of the intestinal DC pool in the steady
state.
The exact contribution of each of these precursors to DC
homeostasis in the lamina propria remains unclear. It also
remains unclear whether the two prominent lamina propria DC
subsets derive from a similar precursor and represent different
stages of DC differentiation or whether they represent two devel-
opmentally distinct DC subsets. Here, we used adoptive transfer
experiments and in vivo-labeling studies to trace the origin of the
lamina propria DC network. Our results establish that mucosal
CD103+CX3CR1
 DCs and CD103CX3CR1
+ DCs derive from
two distinct DC lineages to serve separate immune function in
the intestine.
RESULTS
Phenotype of the Gut DC Network
To examine the phenotype of the DC subsets that populate
different compartments of the small bowel (SB), we isolated the
intestinal epithelial cell (IEC) fraction, the lamina propria depleted
of PPs, the muscularis together with the serosa, and the PPs. Cell
suspensions obtained from each tissue compartment were
analyzed separately by flow cytometry. We found that MHC class
II (MHC II)+CD11chi DCs accumulate mainly in the IEC fraction
and lamina propria and are absent from the muscularis and the
serosa. Mucosal CD11chi DCs can be further divided into two
phenotypically distinct DC populations characterized as MHC IIhi
CD11chiCD103+CD11b+ and MHCIIhiCD11chiCD103CD11b+
DCs (Figures 1A and 1B). A minor DC population characterized
as MHCIIhiCD11chiCD103+CD11b DCs was also detected in
the lamina propria (Figures 1A and 1B). Because of the inability
to fully eliminate lymphoid aggregates from the lamina propria,
we investigated whether the CD103+CD11b DCs in the lamina514 Immunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc.propria are mainly the result of lymphoid tissue contamination.
Consistent with this hypothesis we found that (1) CD103+CD11b
DCs are enriched in PPs, whereas they are absent in the IEC
fraction (Figure 1A); (2) CD103+CD11b DCs are strongly
reduced in mice deficient in the inhibitor of DNA binding protein
2 (Id2) that also lack PPs, whereas CD103+CD11b+ DCs and
CD103CD11b+ DCs remain unaffected in these mice (Fig-
ure 1C); and (3) similar to CD103+CD11b DCs in peripheral
lymphoid organs (not shown), mucosal CD103+CD11b DCs
also express CD8a antigen, whereas CD8a is either not ex-
pressed or expressed at low levels by CD103+CD11b+ DCs and
CD103CD11b+ lamina propria DCs (Figure 1D). Altogether,
these results suggest that the majority of CD103+CD11b DCs
in the SB accumulate in the lymphoid tissue rather than in the
lamina propria. Immunofluorescence studies of SB frozen
sections reveal the presence of CD103+CD11c+ DCs in the
lamina propria and in the intraepithelial space of apical villi,
whereas CD103CD11b+ DCs accumulate mainly in the lamina
propria (Figure 1B; Figures S1A and S1B available online).
CX3CR1 was expressed only by CD103
CD11b+ DCs and was
absent from CD103+ DCs (Figure 1D). Using a reporter mouse
expressing eGFP under the macrophage-colony-stimulating
factor receptor (M-CSFR) (Burnett et al., 2004), we found that
CD103+CD11b+ DCs expressed much lower M-CSFR tran-
scripts levels compared to CD103CD11b+ DCs (Figure 1D).
We further established that the macrophage marker F4/80 was
expressed at higher levels on CD103CD11b+ DCs compared
to CD103+CD11b+ DCs (Figure 1D). Giemsa staining revealed
that, in contrast to CD103+CD11b+ DCs, CD103CD11b+ DCs
present a vacuolar cytoplasm resembling that of macrophages
(Figure 1E). CD103+CD11b+ and CD103CD11b+ lamina propria
DCs loaded with ovalbumin peptide were both efficient at
priming naive ovalbumin-specific TCR transgenic CD4+ T cells,
establishing their antigen-presenting function (Figure 1F). In
contrast to the mucosa, the muscularis and serosa contained
only one homogeneous DC population characterized as
MHCIIhiCD11cloCD103CD11b+ cells that also expressed
CX3CR1 and the macrophage markers F4/80 and M-CSFR (Fig-
ures 1A and 1D; Figure S1C).
Altogether these data show that the lamina propria contains
two DC populations that include MHCII+CD11chiCD103+
CD11b+CX3CR1
M-CSFRlo DCs (referred to as CD103+CD11b+
DCs) and MHCIIhiCD11chiCD103CD11b+CX3CR1
+M-CSFRhi
DCs (referred to as CD103CD11b+ DCs), whereas
MHCIIhiCD11chiCD103+CD11bCX3CR1
 DCs (refereed to as
CD103+CD11b DCs) accumulate mainly in the PPs. MHCIIhi
CD11cloCD103CD11b+ DCs are distributed in the muscular
and serosal layers of the gut distant from the lumen. Equivalent
DC subsets have been found in the large bowel (not shown).
The rest of the study will focus mainly on identifying the mecha-
nisms that regulate the development of the CD103+CD11b+
and CD103CD11b+ lamina propria DCs.
The Role of Growth Factors in the Development
of Lamina Propria DCs
Fms-like thyrosine kinase 3 (Flt3) ligand and granulocyte-macro-
phage-colony-stimulating factor (GM-CSF) are two major cyto-
kines in DC development (Merad and Manz, 2009). Flt3 ligand
is a key molecule for the development of lymphoid organ DCs
Immunity
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Figure 1. Characterization of Phenotypically Distinct DC Subsets in the Small Bowel
(A) Single-cell suspensions prepared from different anatomical compartments of the small bowel (SB) including the IEC fraction, lamina propria (LP), serosa with
the intestinal muscularis, and PPs were analyzed by seven-color flow cytometry. The results were compared to the whole SB depleted of PPs (SB without [w/o]
PP). For CD11chi and CD11clo DC definition, gates were set on viable DAPICD45+MHCIIhi cells. CD11chi DCs were further divided into CD103+CD11b,
CD103+CD11b+, and CD103CD11b+ DCs as indicated in the dot plots. Dot plots in the left column show the percentage of CD11chi and CD11clo DCs among
total DAPICD45+MHCIIhi cells. Dot plots in the right column show the percentage of CD103+CD11b, CD103+CD11b+, and CD103CD11b+ DCs among total
MHCIIhiCD11chi or MHCIIhiCD11clo (serosa and muscularis) DCs.
(B) Images show the distribution of CD103+CD11c-YFP+ cells in the villi of distal SB fromCD11c-EYFP transgenic mice. Images are shown at3400 magnification.
Scale bars represent 10 nm.
(C) Dot plots show the percentage of CD103+CD11b, CD103+CD11b+, and CD103CD11b+ DCs among CD45+MHCIIhiCD11chi cells in the SB depleted of PPs
in WT mice and in the total SB of Id2/ mice.
(D) Overlay histograms show the differential MHCII, CD8a, CX3CR1, M-CSFR, and F4/80 expression among each intestinal DC subset.
(E) Images show purified CD103+CD11b+ and CD103CD11b+ SB LP DCs spun onto glass slides and stained with Giemsa. Images are shown at 3600 magni-
fication. Scale bars represent 10 nm.
(F) CFSE-labeled OTII cells were cultured with purified CD103+CD11b+ or CD103CD11b+ SB lamina propria DCs, splenic DCs, or splenic B cells pulsed with
OVA-peptide. Numbers are the percentage of OTII cells that have not proliferated in each group (representative data of two independent experiments done in
triplicates).and mice that lack Flt3 or its ligand have a strong reduction of DCs
in lymphoid organs (Onai et al., 2007a). GM-CSF is a key cytokine
for DC generation in vitro, in mice and humans (Banchereau and
Steinman, 1998), but lymphoid organ DCs develop normally in
mice that lack GM-CSF and GM-CSF receptor (GM-CSFR)(Vremec et al., 1997). M-CSFR ligands play a predominant role
in macrophage development (Pixley and Stanley, 2004), but are
also required for the development of epidermal Langerhans cells
(Ginhoux et al., 2006). However, the exact role of these cytokines
in the development of intestinal DCs has not been clearlyImmunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc. 515
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Figure 2. M-CSFR, Flt3, and GM-CSFR Control the Development of Lamina Propria DCs
(A) Dot plots show the percentage of CD103+CD11b, CD103+CD11b+, and CD103CD11b+ cells among DAPICD45+MHCIIhiCD11chi SB LP DCs in Csf1r/,
Flt3/, and Csf2r/ mice (right panels) or control WT littermates (left panels). PPs were excised from the SB of Flt3/, Csf2r/, and control littermates, but not
from the SB of Csf1r/ and their Csf1r+/+ control littermates.
(B) Bar graphs show the relative change of absolute cell counts among SB lamina propria DC subsets in Csfr1/, Flt3/, and Csf2r/ mice compared to WT
mice. Error bars represent mean ± SD from four (Csf1r/) to six (Flt3/ and Csf2r/) combined experiments. One asterisk represents 0.05 > p > 0.005, and two
asterisks represent p < 0.005.
(C) WT CD45.1+ mice were lethally irradiated and reconstituted with a mixture of 1:1 CD45.1+ WT and CD45.2+ Flt3/ or Csf2r/ BM cells or with a mixture of
1:10 CD45.1+ WT and CD45.2+ Csf1r/ fetal liver cells. Bar graphs show the percentage of CD45.2+ mutant and CD45.1+ WT cells among blood cells (granu-
locytes or monocytes) used as a control and each SB lamina propria DC subset. Error bars represent means ± SD from three simultaneously analyzed exper-
iments. One asterisk represents 0.05 > p > 0.005, and two asterisks represent p < 0.005 as compared to the chimerism of blood granulocytes or monocytes.established. Consistent with the different M-CSFR expression
between the two lamina propria DC subsets, M-CSFR deletion
in Csf1r/ mice dramatically affected the development of
CD103CD11b+ lamina propria DCs, whereas it did not affect
the development of CD103+CD11b+ lamina propria DCs (Figures
2A and 2B; Figure S2A). In contrast, in Flt3/ mice that lack Flt3,
the development of CD103+CD11b+ lamina propria DCs was
strongly impaired, whereas CD103CD11b+ DCs were only
slightly reduced in these mice (Figures 2A and 2B; Figure S2A).
Absence of GM-CSFR in Csf2r/ mice affected mostly the516 Immunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc.development of CD103+CD11b+ lamina propria DCs, whereas
CD103CD11b+ lamina propria DCs were not affected (Figures
2A and 2B; Figure S2A). Circulating monocytes were also
affected in mice that lack M-CSFR or GM-CSFR but were not
affected in mice that lack Flt3 (Figure S2B).
To test whether the requirement for each cytokine receptor
was intrinsic to the DC precursors, we lethally irradiated and
reconstituted wild-type recipient mice with a 1:1 mixture of wild-
type and mutant progenitors lacking specific cytokine receptors,
except for theCsf1r/ chimeras in which we used a 1:10 mixture
Immunity
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engraftment of Csf1r/ progenitors. Consistent with the
defects observed in the mutant mice, we found that M-CSFR
was required for the development of CD103CD11b+ DCs
but not for the development of CD103+CD11b+ lamina propria
DCs (Figure 2C). Flt3 was required for the development of
the two lamina propria DC subsets with a stronger requirement
for CD103+CD11b+ lamina propria DCs compared to
CD103CD11b+ lamina propria DCs (Figure 2C). GM-CSFR
was required for the development of CD103+CD11b+ DCs,
whereas GM-CSFR was dispensable for the development of
CD103CD11b+ lamina propria DCs (Figure 2C). Interestingly,
Csf1r/ progenitors failed to give rise to Gr-1lo but not to
Gr-1hi blood monocytes, whereas Flt3/ and Csf2r/ progeni-
tors gave rise to monocytes comparable in numbers to the wild-
type (Figure S2C). These results suggest that the monocyte
defect observed in GM-CSFR-deficient mice was not intrinsic
to the DC precursors.
The Dual Origin of the Lamina Propria DC Network
To examine whether different cytokine requirements among
lamina propria DCs reflected their different origin, we sought to
identify the specific hematopoietic progenitor that gives rise to
each specific DC population in the lamina propria. We injected
purified MDPs, CDPs, pre-DCs, and monocytes into untreated
congenic mice and 7 days later, we measured their capacity
to differentiate into intestinal DCs. In this assay, MDPs gave
rise to all mucosal DC subsets including CD103+CD11b+ and
CD103CD11b+ lamina propria DCs and to CD103+CD11b
PP DCs (Figure 3A). CDP gave rise to CD103+CD11b PP DCs
and CD103+CD11b+ lamina propria DCs but not to
CD103CD11b+ lamina propria DCs (Figure 3A). Consistently,
pre-DCs that derive from CDPs gave rise to CD103+CD11b
DCs and to CD103+CD11b+ DCs but not to CD103CD11b+
DCs. These results establish that in addition to giving rise to
lymphoid organ DCs, pre-DCs also give rise to CD103+CD11b
lamina propria DCs as well as to CD103+CD11b PP DCs.
MDPs’ contribution to CD103+ lamina propria DCs was always
greater than their contribution to CD103 lamina propria DCs
(Figure 3A). These results may either reflect MDPs’ intrinsic
potential to preferentially differentiate into CD103+ DCs or only
reflect the higher turnover rate of CD103+ DCs, which increases
the probability of these cells to be replaced by blood precursors
(Jaensson et al., 2008). To address this question, we examined
the steady-state turnover of lamina propria and PP DCs by using
parabiotic mice. Parabiotic mice share blood circulation but
have separated organs for extended period of time, providing
a useful model to trace the physiological turnover of blood-
derived cells. Two weeks after parabiosis was established, we
found that the proportion of donor parabiont-derived DCs was
higher among CD103+ lamina propria DCs compared to
CD103CD11b+ lamina propria DCs (Figure 3B). These results
suggest that CD103+CD11b PP DCs and CD103+CD11b+
lamina propria DCs have a higher probability to be replaced by
short-lived adoptively transferred blood precursors than
CD103CD11b+ lamina propria DCs. CDP did not give rise to
CD103CD11b+ lamina propria DCs in this assay, which, again,
may reflect the slow turnover rate of these cells (Figure 3B) or
suggest that MDP contribution to CD103CD11b+ DCs is mainlyprovided by monocytes. However, no monocyte-derived DCs
were recovered in the lamina propria upon monocyte adoptive
transfer experiments in the steady state (Figure 3A).
Because MDPs have a greater proliferation potential than
monocytes and CDPs, their potential to give rise to lamina prop-
ria DCs with longer half-life will always be greater than that of its
downstream progenitors.
To address this caveat, we adoptively transferred MDPs, CDPs,
pre-DCs, or monocytes into recipient mice depleted of lamina
propria DCs. To eliminate lamina propria DCs, we used chimeric
mice reconstituted with bone marrow cells isolated from trans-
genic mice expressing the diphtheria toxin receptor (DTR) under
the CD11c promoter (CD11c-DTR). Chimeric mice were injected
with diphtheria toxin (DT) prior to adoptive cell transfer for tissue
DC depletion in vivo (Jung et al., 2002; Varol et al., 2007).
Similar to naive mice, in DT-treated mice, MDP differentiated into
all lamina propria DC populations, whereas CDPs and pre-DCs
contributed mainly to CD103+CD11b PP DCs and
CD103+CD11b+ lamina propria DCs (Figure 3C). In contrast to
the results observed in naive mice, Grhi monocytes gave rise to
lamina propria DCs in DT-treated mice. Importantly, Gr1hi mono-
cytes contributed mainly to the CD103CD11b+ lamina propria
DC subset but they did not give rise to CD103+CD11b PP DCs
or CD103+CD11b+ lamina propria DCs (Figure 3C). These results
suggest that CDP and pre-DCs do not contribute substantially to
the CD103CD11b+ lamina propria DC pool in the steady-state
gut,orevenunder conditionsofDCdepletion,whereas monocytes
differentiate mainly into CD103CD11b+ lamina propria DCs.
Monocytes Do Not Give Rise to CD103+CD11b+ Lamina
Propria DCs in the Steady State
Our results showing that adoptively transferred monocytes may
give rise only to CD103CD11b+ lamina propria DCs in DC-
depleted mice because of the slow turnover of CD103CD11b+
lamina propria DCs as suggested by the parabiotic mouse data
(Figure 3B). Another possibility is that DT influences monocyte
and DC differentiation by inducing a favorable tissue inflamma-
tory milieu. To address this caveat, we sought to trace geneti-
cally labeled monocytes in vivo by using the LysM-Cre 3
Rosa26-floxstopfloxEGFP mice (Jakubzick et al., 2008). In these
mice, Cre activity removes a stop cassette upstream of the
floxed reporter and induces irreversible expression of eGFP in
LysM+ cells and their progeny. Although all monocytes express
LysM, not all monocytes are eGFP+ in these mice (Jakubzick
et al., 2008). We reasoned that DC populations expressing
a much lower fraction of eGFP than blood monocytes could
not be derived primarily from monocytes. Our results show that
CD103CD11b+ lamina propria DCs have eGFP expression
compatible with the monocyte origin (Figure 3D). Consistent
with the results above, CD103+CD11b+ lamina propria DCs
express a much lower amount of eGFP compared to monocytes,
further establishing that they do not primarily derive from mono-
cytes in the steady state (Figure 3D).
Lamina Propria DC Populations Have Different
Migratory Abilities in the Steady State
Tissue-draining LNs contain tissue migratory and resident DCs
(Banchereau and Steinman, 1998). CCR7 controls DC migration
from the tissue to the draining LNs (Forster et al., 1999; Ohl et al.,Immunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc. 517
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Figure 3. Origin of Lamina Propria DCs
(A) Untreated (No DT) CD45.2+ CD11c-DTR chimeric mice were injected i.v. with MDP, CDP, pre-DC, or Gr-1hi monocytes (mono) purified from the BM of CD45.1+
WT mice. Dot plots show the percentage of donor-derived CD45.1+ cells among each SB lamina propria DC subset 7 days after adoptive transfer and represent
three to four independent experiments (n = 1 to 2).
(B) Turnover of lamina propria DCs in parabiotic mice. Each parabiotic pair consisted of a CD45.1+ and CD45.2+ WT mouse with shared blood circulation. Lamina
propria DC chimerism was analyzed 2 weeks after initiation of parabiosis. Each graph shows the mean of the percentage of donor parabiont-derived cells among
SB lamina propria DC subsets in a recipient parabiont. Each data point corresponds to one mouse.
(C) Origin of lamina propria DCs in DC-depleted mice. Twelve hours after DT administration, CD45.2+ CD11c-DTR chimeric mice were injected i.v. with MDP,
CDP, or Ly6Chi monocytes and analyzed as described in (A).
(D) Tracing the origin of lamina propria DCs in reporter mice. Graphs show the mean of the percentage of eGFP+ cells among SB lamina propria DC subsets in
LysM-Cre 3 Rosa26-stopfloxEGFP mice. Each data point corresponds to one mouse.2004), and specific DC defects in the draining LNs of Ccr7/
mice have been used to distinguish tissue migratory DCs from
LN resident DCs in the steady state. CD103+ DCs are reduced in
the MLNs in the absence of CCR7 (Johansson-Lindbom et al.,
2005). However, it is unclear in this published study whether
CD103+CD11b+ lamina propria DCs are specifically affected in
CCR7-deficient mice. It is also unclear whether CD103CD11b+
lamina propria DCs are affected in these mice.
To compare the constitutive migratory ability of lamina propria
DC subsets, we examined the phenotype of MLN DCs in naive518 Immunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc.mice. CD103+CD11b+ DCs phenotypically identical to those
present in the intestinal mucosa (not shown) were also present
in the MLNs (Figure 4A). In contrast to CD103CD11b+ lamina
propria DCs, CD103CD11b+ DCs in the quiescent MLNs ex-
pressed much fewer CX3CR1 molecules on the cell surface (Fig-
ure 4A), suggesting that either CD103CD11b+CX3CR1
+ lamina
propria DCs do not migrate to the MLNs in the steady state or
that CX3CR1 expression is downregulated during DC migration.
To address this caveat, we used LysM-Cre 3 Rosa26-floxstop-
floxEGFP mice to trace the migration of genetically labeled
Immunity
Origin of the Gut DC Networklamina propria DCs to the draining LNs (Jakubzick et al., 2008).
We found that 90% of CD103CD11b+ lamina propria DCs are
eGFP+, whereas the eGFP expression among each MLN DC
subset did not exceed 20% (Figure 4B). Because eGFP expres-
sion is irreversible in these mice, these results establish that
CD103CD11b+CX3CR1
+ lamina propria DCs are unlikely to
migrate to the MLNs in the steady state. Consistent with
these results, CCR7 was expressed at much higher amounts
in CD103+CD11b+ lamina propria DCs compared to
CD103CD11b+ lamina propria DCs (Figure 4C). Moreover,
CD103+CD11b+ DCs were strongly reduced in the MLNs of
Ccr7/ mice in the steady state, whereas CD103CD11b+
MLN DCs remained unaffected in these mice (Figures 4D and
4E). The distribution of lamina propria DCs in Ccr7/ mice
was also not affected (not shown). Altogether these results
suggest that the CD103+CD11b+ DC subset represents the
main migratory DC population in the lamina propria in the steady
state.
CD103+CD11b+ Lamina Propria DCs Are the First DCs
to Deliver Pathogenic Bacteria to the MLNs
The striking differential CCR7 expression among lamina propria
DCs prompted us to examine the differential role of the lamina
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Figure 4. Migration of the Lamina Propria
DC Subsets to the MLN in the Steady State
(A) Dot plots show the percentage of
CD103+CD11b, CD103+CD11b+, and CD103
CD11b+ DCs among DAPICD45+MHCIIhiCD11c+
MLN DCs (left panel). Histograms show the
CX3CR1 expression on gated CD103
CD11b+
MLN DCs compared to CD103CD11b+ SB
lamina propria DCs isolated from Cx3cr1GFP/+
knockin mice.
(B) Dot plots show the percentage of eGFP+ cells
among total CD103+CD11b, CD103+CD11b+,
and CD103CD11b+ SB lamina propria DCs (left
column) and MLN DCs (right column) in LysM-
Cre 3 Rosa26-stopfloxEGFP mice. Data represent
one of three independent experiments.
(C) Bar graphs show CCR7 mRNA relative
expression units (RU) in purified CD103+CD11b+
and CD103CD11b+ SB lamina propria DCs
compared to purified splenic DCs from naive WT
mice. The bar graph shows the mean ± SD of
data from four independent cell purifications
tested in the same qPCR reaction.
(D and E) Dot plots and bar graph show the (D) rela-
tive and (E) absolute numbers of CD103+CD11b,
CD103+CD11b+, and CD103CD11b+ MLN DCs
in WT and Ccr7/ mice. Data represent the
mean ± SD of four combined experiments.
propria DC populations in the early trans-
port of pathogens from the intestinal tract
to the MLNs upon oral infection. To
address this question, we orally infected
streptomycin-pretreated mice with wild-
type Salmonella Typhimurium (S. Typhi-
murium) to enforce Salmonella invasion
through the lamina propria, providing
a clinically relevant mouse model of salmonellosis (Barthel
et al., 2003). We found that 24 hr after oral infection,
CD103+CD11b+ DCs were the only DCs in the MLN that carried
intracellular Salmonella (Figures 5A–5C) even though both
CD103+CD11b+ and CD103CD11b+ DC subsets contained
intracellular Salmonella in the lamina propria at this time point
(Figures 5D and 5E). In contrast, after systemic infection, all
DC subsets in the MLN contained Salmonella antigen
(Figure 5A). Consistent with previous studies, Salmonella-
carrying cells were not detected among mucosal and MLN
CD103+CD11b DCs of orally infected mice, suggesting that in
this model Salmonella invades mainly through the lamina propria
and not PPs (Barthel et al., 2003).
Absence of Lamina Propria CD103+CD11b+ DCs Impairs
the Dissemination of Oral Salmonella to MLNs
To examine whether the absence of CD103+CD11b+ lamina
propria DCs affects the transport of intestinal pathogens to
MLNs, we infected streptomycin-pretreated Flt3/ mice, which
lack CD103+CD11b+ lamina propria DCs and have reduced
numbers of CD103+CD11b PP DCs, with S. Typhimurium either
orally or systemically. Strikingly, 2 days after oral infection,
Salmonella dissemination to MLNs (Figure 6A) and spleen (notImmunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc. 519
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Figure 5. CD103+CD11b+ DCs Are the First DCs to Transport Salmonella Typhimurium to the MLN after Oral Infection
(A–C) Mice were infected with Salmonella either orally (per os, p/o) or intraperitoneally (i/p). Eighteen hours (i/p) or twenty-four hours (p/o) after infection, MLNs
were collected and MLN single-cell suspensions were stained for DC surface markers and intracellular Salmonella CSA and subjected to flow cytometry.
(A) Dot plots show the percentage of Salmonella+ cells among each MLN DC subset after p/o or i/p infection compared to uninfected controls.
(B) The bar graph shows the absolute number of Salmonella+ (SAL+) cells among each MLN DC subset 24 hr after oral infection. Data represent the mean ± SD of
three independent experiments.
(C) Images show Salmonella+ cells among purified CD103+CD11b+, CD103+CD11b, and CD103CD11b+ MLN DC 24 hr after oral infection. Peritoneal macro-
phages (Per. Mf) isolated 4 hr after i/p infection were used as a positive control. Images are shown at 3600 magnification. The scale bar represents 10 nm.
(D and E) Twenty-four hours after oral infection with Salmonella, SB cell suspension was stained for DC surface markers and intracellular Salmonella antigens and
analyzed by flow cytometry.
(D) Dot plots show the percentage ofSalmonella+ cells among each SB lamina propria DC subset after oral (per os, p/o) infection compared to uninfected controls.
(E) Images show Salmonella+ cells among purified SB lamina propria CD103+CD11b+ and CD103CD11b+ but not CD103+CD11b DCs after oral infection.
Images are shown at 3600 magnification. The scale bar represents 10 nm.shown) was strongly reduced in Flt3/ mice compared to wild-
type mice, whereas bacterial loads in the SB were comparable
between each group. In contrast, the rate of Salmonella dissem-
ination upon systemic infection was similar in mutant and wild-
type mice (not shown). Given that in orally infected strepto-520 Immunity 31, 513–525, September 18, 2009 ª2009 Elsevier Incmycin-pretreated mice, Salmonella invades mainly though the
lamina propria and not PP (Barthel et al., 2003), these results
suggest that CD103+CD11b+ DCs are the main DC population
that transports Salmonella from the intestinal tract to the
MLNs. Reduced bacterial dissemination to the MLNs was also.
Immunity
Origin of the Gut DC Networkobserved in Ccr7/ mice, further supporting the key role of
tissue migratory DCs in the transport and dissemination of intes-
tinal pathogens to the draining LNs (Figure 6B). Altogether, these
results establish the key role of CD103+CD11b+ lamina propria
DCs in the transport of pathogens to MLNs.
DISCUSSION
Our results establish the dual origin of the DC network that
populates the intestinal mucosa in the steady state. Here, we
showed that the lamina propria DC network consisted of DCs
derived from monocytes and pre-DCs. Lamina propria DCs
derived from pre-DCs are migratory and participate in antigen
trafficking and immunosurveillance. The function of the mono-
cyte-derived mucocsal DCs remains to be elucidated.
CD103+ and CX3CR1
+ DCs represent two distinct mucosal
DC subsets in the lamina propria. CX3CR1 is expressed mainly
by lamina propria CD103CD11b+ DCs, whereas CD103 is
expressed on CX3CR1
CD11b+ lamina propria DCs and
CD11bCD8a+ DCs in the PP. CX3CR1 is also expressed on
MHCIIhiCD11clo DCs, a population initially characterized as
lamina propria macrophages (Denning et al., 2007), that accu-
mulates mainly in the intestinal muscularis and the serosa distant
from the lumen.
CD103+CD11b+ lamina propria DCs arise from CDP and pre-
DCs independently of monocytes. CDP localizes in the BM and
has been shown to give rise to pre-DCs (Liu et al., 2009) and
plasmacytoid DCs in the blood and to classical DCs in the spleen
and peripheral LN but not to monocytes or macrophages (Naik
et al., 2007; Onai et al., 2007b), whereas pre-DCs have lost
B
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Figure 6. Transport of Salmonella Typhimurium to the MLN Is
Impaired in Flt3/ Mice
(A) Graphs show mean of Salmonella colony-forming units (CFUs) recovered
from the homogenized terminal SB and total MLN of WT and Flt3/ mice 2
days after oral Salmonella infection. Each data point corresponds to one
mouse. Data represent the results of three independent experiments.
(B) Graphs show mean of Salmonella CFU recovered from the homogenized
total MLN of WT and Ccr7/ mice 2 days after oral Salmonella infection.
Data represent the results of three independent experiments. Each data point
corresponds to one mouse.Ima plasmacytoid DC potential and give rise only to lymphoid organ
DCs (Liu et al., 2009). Here, we showed that in addition to giving
rise to lymphoid organ DCs, CDPs and pre-DCs also give rise to
CD103+CD11b+ but not CD103CD11b+ lamina propria DCs.
Flt3 ligand is a key cytokine in DC differentiation in vivo. CDP
and pre-DCs express high levels of Flt3 (Liu et al., 2009; Naik
et al., 2007; Onai et al., 2007b), and the loss of Flt3 expression
among hematopoietic progenitors coincides with the loss of
DC differentiation potential (Onai et al., 2007a). Conversely, en-
forced Flt3 gene expression among Flt3-negative hematopoietic
progenitors rescues their DC differentiation potential (Onai et al.,
2006), establishing the instructive role of Flt3 in DC differentiation
in the BM. In addition to its role on progenitors, Flt3 also controls
the homeostasis of differentiated DCs in lymphoid organs (Was-
kow et al., 2008). Consistent with the key role of Flt3 in DC differ-
entiation in vivo, our results establish that CD103+CD11b+
lamina propria DCs represent the DC population most strongly
affected in the absence of Flt3. Similar results were obtained in
FLT3-ligand-deficient mice (not shown).
In addition to Flt3 ligand, we showed that GM-CSF controlled
the development of CD103+CD11b+ lamina propria DCs.
GM-CSF is a key cytokine for DC generation in vitro, in mice
and humans (Banchereau and Steinman, 1998). Therefore, it
came as a surprise that mice that lack GM-CSF or its receptor
do not have any DC developmental defect in lymphoid organs
(Vremec et al., 1997). Subsequent results suggested that GM-
CSF participates only in the development of DCs in inflamed
lymphoid tissue (Naik et al., 2006). However, we showed that
GM-CSF also controls the differentiation of lamina propria DCs
in the steady state.
In contrast to CD103+CD11b+ lamina propria DCs,
CD103CD11b+ DCs arise from Ly6Chi monocytes and not
from CDP or pre-DCs. Upon adoptive transfer, Ly6Chi mono-
cytes have been shown to shuttle back to the BM to give rise
to blood-circulating Ly6Clo monocytes (Varol et al., 2007). There-
fore, it is possible that Ly6Chi monocyte contribution to lamina
propria DCs is mediated mainly through Ly6Clo monocytes.
Consistent with their high M-CSFR expression, differentiation
of CD103CD11b+ lamina propria DCs is strongly dependent
on M-CSFR ligands. M-CSFR plays a key role in macrophage
differentiation and is thought to control the differentiation, prolif-
eration, and survival of macrophages in vivo (Pixley and Stanley,
2004). One of the M-CSFR ligand, M-CSF, is expressed in the
BM but also in the lamina propria (Klebl et al., 2001), suggesting
a potential role for M-CSF not only at the progenitor level but also
at the tissue site. More recently, a second M-CSFR ligand has
been identified in mice and humans. This ligand named inter-
leukin-34 binds to M-CSFR with higher affinity than M-CSF (Lin
et al., 2008). The exact contribution of each M-CSFR ligand to
lamina propria DC development in vivo remains to be estab-
lished. It also remains to be established whether M-CSFR
signaling is required mainly at the progenitor level in the BM or
at the tissue site. These results extend the role of M-CSFR in
hematopoietic cell development and establish that in addition
to its role in the development of macrophages and epidermal
Langerhans cells, M-CSFR also controls the development of
a specific monocyte-derived DC subset in the lamina propria.
In addition to giving rise to spleen and peripheral lymphoid
organ DCs, CDPs and pre-DCs also give rise to CD103+munity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc. 521
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Origin of the Gut DC NetworkCD11b PP DCs. CD103+CD11b DCs were also strongly
dependent on Flt3 ligand, but in contrast to lamina propria
CD103+CD11b+ DCs, they developed independently of GM-
CSF. These results are consistent with the data showing that
the absence of GM-CSF or GM-CSFR does not affect the devel-
opment of DCs in quiescent lymphoid organs in mice (Vremec
et al., 1997).
Altogether, these results establish the concomitant contribu-
tion of monocytes and committed DC precursors to the nonlym-
phoid tissue DC pool in the steady state and pose the question of
the functional relevance of this dual DC origin. One striking func-
tional difference between the two DC lineages resides in their
ability to survey the gut. Our data showed that pre-DC-derived
CD103+CD11b+ lamina propria DCs constitutively express high
amounts of CCR7, whereas monocyte-derived CD103CD11b+
lamina propria DCs expressed no or low amounts of CCR7 in the
steady state. Consistently, CD103+CD11b+ lamina propria DCs
are the predominant DC population affected in the MLNs of
CCR7-deficient mice. These results are consistent with previous
studies showing that CD103+ DCs are the main DC population
that present oral antigens to MLN T cells in the steady state
(Jaensson et al., 2008). The potency of CD103+ DCs to induce
T regulatory cells was shown to be dependent on their superior
ability to produce retinoic acids as compared to the CD103
DCs (Coombes et al., 2007; Sun et al., 2007). The unique
ability of CD103+CD11b+ DCs to migrate to the draining LNs
in the steady state may provide another advantage over
CD103CD11b+ lamina propria DCs to present luminal antigens
in MLNs in a tolerogeneic context.
In contrast to CD103+CD11b+ lamina propria DCs, monocyte-
derived lamina propria DCs do not substantially migrate to the
draining LNs in the steady state. It is, however, surprising that
these cells uniquely express CX3CR1, a molecule shown to
control the formation of DC protrusions and the sampling of
luminal antigens (Niess et al., 2005; Rescigno et al., 2001a);
such a finding raises the question as to the purpose of antigen
sampling if antigens are not to be transported to the LNs. One
possibility is that CX3CR1-dependent sampling is more physio-
logically relevant during intestinal inflammation because DC
protrusions, although present in the steady state, dramatically
increase during infection (Chieppa et al., 2006). Another possi-
bility is that the capture of luminal antigens by monocyte-derived
DCs triggers cytokine secretion that modulates the tissue
immune environment either locally or through the control of
CD103+CD11b+ DC migration to the MLNs. Another tempting
hypothesis is that CD103CD11b+CX3CR1
hi DCs provide
luminal antigens to CD103+CD11b DCs, and we are currently
testing such a possibility.
CD103+CD11b+ lamina propria DCs are located in close
proximity to the epithelial layer, suggesting that they too might
be able to sample antigens. The integrin CD103 is a ligand for
E-cadherin, an adhesion molecule expressed by epithelial
cells (Cepek et al., 1994), and may promote the homing of
CD103+CD11b+ lamina propria DCs to the gut epithelia, thereby
facilitating the ability of the CD103+CD11b+ lamina propria DCs
to sample cell-associated antigens. Another possibility is that
they acquire antigens directly through PP-independent M
cells (Jang et al., 2004) or through cross-presentation of the
CD103CD11b+ lamina propria DCs as suggested above.522 Immunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc.Using a S. Typimurium oral infection model in streptomycin-
pretreated mice to enforce pathogen invasion through the
epithelia rather than PP (Barthel et al., 2003), we also established
the superior ability of CD103+CD11b+ lamina propria DCs to
transport gut pathogens to the MLNs. Although this model was
described to affect mostly the large bowel, we consistently
observed distal SB inflammation starting 1 day after the infection
(not shown). Expression of TLR5 by gut DCs was shown to play
a key role in DC transport of Salmonella to the draining LNs
(Uematsu et al., 2006). Although, we found that both mono-
cyte-derived and CDP-derived DCs express TLR5 (not shown),
CD103+CD11b+ lamina propria DCs were the first to transport
the pathogen to the MLNs. DC ability to transport antigens
from the intestinal tract to the MLNs, although critical for initiation
of systemic immunity against gut pathogens, can be used by
facultative pathogens to disseminate in the host. This was
most clearly shown in a model of S. Typhimurium infection, in
which the inability of Tlr5/ DCs to transport the pathogen to
the MLNs improved the infection outcome by reducing the
systemic dissemination of the pathogen (Uematsu et al., 2006).
It is likely that the specific depletion of CD103+CD11b+ lamina
propria DCs may also improve mice survival upon oral Salmo-
nella infection by reducing or delaying pathogen transport in
the MLNs.
Altogether, these results identify the dual origin of the lamina
propria DC network. CD103CD11b+ lamina propria DCs arise
from circulating monocytes under the control of M-CSFR ligand
and to a lesser degree Flt3 ligand, whereas CD103+CD11b+
lamina propria DCs derive from DC-restricted progenitors under
the control of Flt3 ligand and GM-CSF. In contrast to monocyte-
derived DCs, lamina propria DCs that arise from pre-DCs consti-
tutively migrate to the MLNs in the steady state and excel in the
induction of peripheral Foxp3+ T regulatory cells (Coombes et al.,
2007; Sun et al., 2007). They also represent the first DC popula-
tion to migrate to the draining LNs in the inflamed setting,
probably playing a key role in gut immunosurveillance. These
results underline the developmental and functional diversity of
the mucosal DC network and suggest that oral immunization
strategies could be substantially optimized by targeting specific
DC populations in the lamina propria.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (CD45.2+), congenic CD45.1+ C57BL/6, transgenic Mafia mice
[C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck/J] (Burnett et al.,
2004), OVA TCR transgenic OT II mice [C57BL/6-Tg(TcraTcrb)425Cbn/J],
transgenic CD11c-DTR mice (B6.FVB-Tg Itgax-DTR/GFP 57Lan/J), and
Csf2r/ mice (B6.129S1-Csf2rbtm1Cgb/J) were purchased from the Jackson
Laboratory (Jackson Laboratory, Bar Harbor, ME, USA). Cx3cr1
GFP/GFP
C57BL/6 knockin mice were provided by D. Littman (Skirball Institute, New
York, NY, USA) and bred with WT C57BL/6 mice for obtaining heterozygote
Cx3xr1
GFP/ mice. Transgenic C57BL/6 mice expressing an enhanced yellow
fluorescence protein (EYFP) reporter under the control of the CD11c promoter
were generated as described (Lindquist et al., 2004). Flt3/ C57BL/6 mice
were kindly provided by I. Lemischka (Mount Sinai School of Medicine,
New York, NY, USA). Id2/ were kindly provided by Y. Yokota (University of
Fukui, Japan). Csf1r/ FVB/NJ mice and Csf1r/ C57BL/6 were provided
by E.R.S. (Albert Einstein College of Medicine, Bronx, NY, USA). All mice
were analyzed between 8–12 weeks of age with the exception for Csf1r/
mice, which were analyzed at 3 weeks of age because of their early lethality.
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developed as described (Jakubzick et al., 2008). Mice were housed in a
specific pathogen-free environment at Mount Sinai School of Medicine and
were used in accordance with protocols approved by the Institutional Animal
Care and Utilization committee.
Isolation of Intestinal Cell Suspensions
For preparation of single-intestinal-cell suspension, parts of small bowel (SB),
including jejunum and ileum, or large bowel (cecum and colon) were excised
by separation from the mesentery. Intestines were opened with scissors along
the intestinal length. Next, intestinal tissues were incubated on a shaker in
complete medium (CM, 2% FBS in Ca2+, Mg2+-free HBSS; Cellgro, Herndon,
VA, USA) in the presence of 1 mM DTT (Sigma-Aldrich, St. Louis, MO, USA) at
37C for 20 min and subsequently incubated with 1.3 mM EDTA (Cellgro) in
CM at 37C for 1 hr. The supernatants containing intestinal epithelial cell (IEC)
with some superficial villi cells, referred to as the ‘‘IEC fraction,’’ were collected
and analyzed by flow cytometry. For analysis of DC subset distribution in
different anatomical compartments of SB, PPs were excised with scissors;
the intestinal muscularis covered by the serosa was peeled from the submucosa
with the use of fine surgical forceps and a dissection microscope (model SZ51;
Olympus). SB villi representing intestinal lamina propria were scraped from the
underlying submucosa. Isolated tissues were collected and digested with
0.2 mg/ml of type IV collagenase (Sigma-Aldrich) at 37C for 1 hr. Tissues
were then homogenized, filtered, and washed. For the enrichment of CD11chi
lamina propria DCs, PPs were always excised and the intestinal muscularis
was routinely separated from the rest of the tissue (mucosa and submucosa)
and either discardedor subjected toa separateanalysis.Single-cell suspensions
were stained with mAbs and analyzed by flow cytometry. MLNs and splenic cell
suspensions were prepared by digestion with type IV collagenase for 20 min.
Mixed Bone Marrow Chimeras
Eight-week-old CD45.1+ C57BL/6 recipient mice were lethally irradiated with
1200 rad delivered in two doses of 600 rad each (Cesium source) 3 hr apart
and injected intravenously (i.v.) with 53105 bone marrow (BM) cells or fetal liver
cells. Mice were reconstituted with a mixture of 50% wild-type (WT) CD45.1+
and 50% Flt3/, Csf2r/, or WT CD45.2+ BM cells or with 10% WT
CD45.1+ BM cells and 90% CD45.2+ fetal liver cells isolated from Csf1r/ or
control littermates. E14.5 fetal liver was used in this case because C57BL/6
Csf1r/ mice are embryonically lethal. CD45.1+ C57BL/6 recipients trans-
planted with 100% WT CD45.2+ BM were used for controlling the complete
replacement of recipient hematopoietic cells with donor BM-derived cells. In
all transplanted mice, engraftment was assessed by measuring the relative
numbers of donor cells among blood SSCloCD115+Ly6C/Ghi monocytes or
SSCintCD11b+Ly6C/G+ granulocytes 3 to 4 weeks after transplantation.
Parabiosis
Parabiotic mice were generated as described previously (Wright et al., 2001).
Each pair of parabiotic mice consisted of CD45.1+ and CD45.2+ WT C57BL/6
parabionts with shared blood circulation. Two weeks after initiation of parabi-
osis, mice were sacrificed and subjected to tissue analysis. For confirmation of
efficient blood mixing in parabiotic mice, the percentage of CD45.1+ and
CD45.2+ among blood CD45+ leukocytes was analyzed in each animal.
Salmonella Infection In Vivo
The naturally streptomycin-resistant wild-type Salmonella enterica subspecies
1 serovar Typhimurium (S. Typhimurium) SL1344 strain (Hoiseth and Stocker,
1981) was grown in Luria-Bertani (LB) broth for 18 hr, harvested by centrifuga-
tion, and resuspended in cold PBS. Bacterial concentration was estimated by
measuring optical density at 420 nm and confirmed by plating bacterial dilu-
tions of LB agar plates. OD420 of 1 is equal to 1 3 10
8 CFU/ml (Singh et al.,
2000). For inducing Salmonella-dependent enterocolitis, mice were infected
in accordance with the previously described protocol (Barthel et al., 2003).
In brief, mice were pretreated by gavage with 20 mg of streptomycin.
Twenty-four hours later, mice were orally infected with 5 3 107 CFU of strep-
tomycin-resistant wild-type S. Typhimurium. For assessment of the mortality
rate from systemic infection, mice were injected with 5 3 104 S. Typhimurium
intraperitoneally (i.p.). For detection of intracellular S. Typhimurium in MLN
DCs, mice were infected i.p. with 1 3 106 CFU of S. Typhimurium and sacri-Ificed 18 hr after infection. Live bacterial loads in the intestinal tissues and
MLNs were determined by plating serial dilutions of homogenized tissues on
LB agar plates supplemented with 50 mg/ml of streptomycin (Calbiochem,
Gibbstown, NJ, USA).
Flow Cytometry
Multiparameter (up to seven colors) analyses of stained cell suspensions were
performed on the LSR II (Becton Dickinson, San Jose, CA, USA) and analyzed
with FlowJo software (Tree Star, Ashland, OR, USA). Fluorochrome or biotin-
conjugated monoclonal antibodies (mAbs) specific to mouse B220 (clone
RA3-6B2), CD8a (clone 53-6.7), MHC class II (I-A/I-E, clone M5/114.15.2),
CD103 (clone 2E7), CD11b (clone M1/70), CD11c (clone N418), CD45 (clone
30F11), CD45.1 (clone A20), CD45.2 (clone 104), M-CSFR (also called
CD115) (clone AFS98), Gr-1 (Ly6C/G, clone RB6-8C5), and Va2 (clone
B20.1), the corresponding isotype controls, and the secondary reagent PE-
Cy7-conjugated streptavidin were purchased either from BD Biosciences or
eBioscience (San Diego, CA, USA). Anti-F4/80 (A3-1) mAb was purchased
from Serotec (Raleigh, NC, USA). For detection of intracellularS. Typhimurium,
viable cells were stained for the surface markers, fixed, and permeabilized with
the BD Cytofix/Cytoperm kit (BD Biosciences) in accordance with the manu-
facturer’s protocol and incubated with the FITC-labeled anti-Salmonella
common structural antigens CSA-1 polyclonal Ab (Kirkegaard & Perry Labora-
tories, Gaithersburg, MD, USA) or an isotype control Ab.
Cell Sorting
Single-cell suspensions of viable cells were stained for the surface markers and
individual DC subsets were sorted with FACS-Vantage Flow Cytometer/Cell
Sorter (Becton Dickinson) in accordance with determined phenotypes so that
98% purity could be achieved. Cooling system was applied for prevention of
excessive cell activation and death. One-, two- or three-way sorting was per-
formed. Purified cell phenotypes were as follows: MHCIIhiCD11chiCD11b
CD103+, MHCIIhiCD11chiCD11b+CD103+, and MHCIIhiCD11chiCD11b+
CD103 SB lamina propria DCs; MHCIIhiCD11c+CD11b+CD103+,
MHCIIhiCD11c+CD11b+CD103, and MHCIIhiCD11c+CD11bCD103+ MLN
DCs; MHCIIhiCD11c+CD11b+ splenic DCs; or MHCII+CD11cCD11bB220+
splenic B cells. For sorting cells from infected tissues, cell suspension was fixed
prior to sorting as described above.
Cytospin of Sorted Cells
For examining DC morphology, viable sorted cells were spun onto glass slides,
dried overnight, and stained with Giemsa. Images were analyzed with the
Nikon Eclipse E800 microscope (Nikon, Japan) at 6003 magnification. For
viewing infected cells, MLN cell suspensions were stained for DC cell-surface
markers, fixed, and sorted. Purified DC subsets were stained with the
FITC-labeled anti-Salmonella CSA-1 polyclonal Ab (Kirkegaard & Perry Labo-
ratories), spun onto glass slides, and mounted with the Vectashield mount
medium containing DAPI (Vector Laboratories, Burlingame, CA, USA). Images
were acquired at 6003 magnifications with a Leica DMRA2 fluorescence
microscope with a Hamamatsu CCD digital camera and analyzed with
Openlab software (Improvision, Waltham, MA, USA).
Immunofluorescent Analysis of Intestinal Cross-sections
Prior to organ collection,CD11c-EYFP transgenic mice orCx3cr1
GFP/ knockin
mice were perfused i.v. with 2% formaldehyde/20% sucrose in PBS solution
so that intracellular GFP/YFP could be preserved. Organs were then harvested
and rinsed in PBS before freezing in optimum cutting temperature compound.
Six-mm-thick cross-sections of terminal ileum were placed on Superfrost/Plus
microscope slides (Fisher Scientific, Pittsburgh, PA, USA), incubated with 5%
goat serum and 0.5% Triton in PBS for 30 min, and subsequently stained over-
night with the primary antibody directed against CD103 (eBioscience). Slides
were then washed in PBS with 0.1% Triton (Sigma-Aldrich) and stained for
60 min with the secondary goat anti-Armenian hamster IgG-Biotin and subse-
quently with Streptavidin-Cy3 (Cx3cr1
GFP/ mice) or Streptavidin-Cy5 (CD11c-
EYFP mice) from Jackson Immunoresearch Laboratories (West Grove, PA,
USA). Slides were mounted in Vectashield mount medium containing DAPI
(Vector Laboratories). Images were acquired at 2003 and 4003magnification
with a Leica DMRA2 fluorescence microscope with a Hamamatsu CCD digital
camera and analyzed with Openlab software (Improvision).mmunity 31, 513–525, September 18, 2009 ª2009 Elsevier Inc. 523
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Live 103+CD11b+ and CD103CD11b+ SB lamina propria DCs, splenic DCs, or
splenic B cells were sorted as described above. A total of 1 3 104 DCs were
supplemented with 1 mg/ml of OVA323-339 peptide and cocultured with 5 3
104 CD11cCD4+ OT-II T cells labeled with 5 mM CFSE (Molecular Probes/
Invitrogen, Carlsbad, CA, USA) in CM (RPMI, Cellgro; 10% FBS, 0.1%
b-2ME, Sigma-Aldrich; 1% penicillin, 0.1% fungizone, GIBCO/Invitrogen).
Four days later, the proliferation of OT-II T cells (CD11cVa2+TCR+) was
assessed by measurement of the dilution of the CFSE by flow cytometry.
MDP, CDP, Pre-DC, and Monocyte Transfer Experiments
MDPs were sorted as lineage (CD3, TCRb, CD19, B220, Gr1, CD11b,
CD11c, NK1.1, Ter119, pDCA, and MHCII)-negative, CD115+Flt3+c-kithi
cells from the BM of CD45.1+ C57BL/6 mice. CDPs were sorted as
lineageCD115+Flt3+c-kitlo cells from the BM of CD45.1+ C57BL/6 mice,
as described in Onai et al. (2007b). Pre-DCs were sorted as
CD3CD19NK1.1Ter119B220I-ACD11cintFlt3+SIRPaint from the BM of
CD45.1+ C57BL/6 mice, as described in Liu et al. (2009). Ly6Chi monocytes
were sorted as described in Ginhoux et al. (2006) from CD45.1+ bone marrow.
A total of 33 105 MDP, 53 105 CDP, and between 1.5 and 23 106 monocytes
were injected i.v. into either untreated or DT-treated CD45.2+ CD11c-DTR
chimeric mice. DT (List Biological Laboratories, Campbell, CA, USA) was
reconstituted and stored in accordance with the manufacturer’s protocol. For
CD11chi cell depletion, CD11c-DTR mice were injected with 5 ng/g of DT intra-
peritoneally 12 hr prior to cell transfer.
Quantitative PCR
Total RNA from sorted DC subsets was extracted with the RNeasy micro Kit
(QIAGEN, Valencia, CA, USA) in accordance with the manufacturer’s instruc-
tions. Reverse transcription was performed with RNA from 5 3 104 to 1 3 105
cells, and RNA concentration was standardized for all the samples. Quantita-
tive PCR was conducted in duplicates. Relative expression levels were calcu-
lated as 2ˆ (Ct Ubiquitin  Ct gene) with ubiquitin RNA as the endogenous
control. For confirmation of the results, two distinct sets of primers for mouse
CCR7 were used in qPCR analysis. The sequences for the CCR7 primers were
as follows: CCR7 F1: 50-CACGCTGAGATGCTCACTGG-30, CCR7 R1: 50-CC
ATCTGGGCCACTTGGA-30; CCR7 F2: 50-TCCAGGCACGCAACTTTGA-30,
CCR7 R2: 50-CCACCACGGCAATGATCAC-30. PCR primers were ordered
from Integrated DNA Technologies, USA.
Statistical Analysis
Data are presented as mean ± SD. The statistical significance of differences
between group means was determined with the Student’s t test. p values
of < 0.05 were considered significant.
SUPPLEMENTAL DATA
Supplemental Data include two figures and can be found with this article online
at http://www.cell.com/immunity/supplemental/S1074-7613(09)00368-9.
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